RNA vaccines can genetically modify us. Dr. María José Martínez Albarracín, Surgeon, professor of clinical diagnostic processes, expert in immunology, biochemistry and laboratory techniques. Link to video: click here.
Days after the FDA approved Johnson & Johnson, J&J’s COVID vaccine for emergency use, the company announced plans to test the vaccine in newborns, despite the risks of the vaccine and the strong evidence that COVID poses virtually no risk to healthy infants.
Recently, the U.S. Food and Drug Administration (FDA) granted Food and Drug Administration Clearance (FDA) approval for COVID in newborns. (FDA) granted Emergency Use Authorization for COVID vaccine to Johnson & Johnson (J&J) , paving the way for the vaccine to be administered beginning the first week of March, 2021.
The Centers for Disease Control and Prevention (CDC) also recommended the vaccine for people over the age of 18. On Sunday, J&J unveiled plans to test its single-injection vaccine in infants, including newborns, pregnant women and the immunosuppressed. The expanded clinical trials were set forth in the company’s application for emergency use approval and in briefing materials provided to the FDA and briefly discussed during the meeting.
According to the New York Times , the expanded clinical trial plan won the approval of Ofer Levy, M.D., director of the Precision Vaccines Program at Harvard’s Boston Children’s Hospital and a member of the FDA advisory committee that reviewed the company’s vaccine data.
When Levy saw the outlines of the planned trials, he said, “They didn’t go into a lot of detail about it, but they made it clear that they will conduct pediatric and maternal coronavirus immunization studies.”
A spokesman for Janssen Biotech, a subsidiary of J&J, confirmed that the company plans to extend the clinical trials to children, first to children aged 12 to 18 years, and immediately thereafter to newborns and adolescents, then to pregnant women and immunocompromised individuals.
Levy noted that vaccinating children will help the country achieve herd immunity, echoing comments made by Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, during Sunday’s Meet the Press :
“Vaccinating young people will be necessary to approach herd immunity and significantly slow the spread of COVID-19 in the United States. While they generally have fewer symptoms than adults with COVID-19, children can still transmit the disease.”
Anthony Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases
After decades of intensive effort “have not achieved herd immunity for any childhood disease” stated Mary Holland has done extensive research on the history of vaccine policies.
Immunologist Tetyana Obukhanych, Ph.D., and others agree that officials use the concept of herd immunity as a “trump card to justify any measure, often contrary to personal freedom of choice, with the goal of increasing vaccination compliance” .
Most of the global vaccine market is pediatric vaccines, according to the Times, so it is not surprising that J&J is looking to capitalize on a relatively untapped market for its coronavirus vaccine. Bill Gates set the stage for a pediatric vaccine last year, declaring his desire to make COVID-19 vaccines “part of the routine newborn vaccination schedule” despite the fact that 99.997% of 0-19 year olds survive COVID-19 and most experience mild or no symptoms .
A study published in the European Journal of Pediatrics showed that only a subset of children, mostly children with serious underlying medical conditions, experienced hospitalization for COVID.
The CDC states, “COVID-19 is uncommon in newborns born to mothers who had COVID-19 during pregnancy. Some newborns tested positive for COVID-19 shortly after birth, but it is unknown when they may have been exposed to the virus. Most infants and newborns who tested positive for COVID-19 had mild or no symptoms and recovered.”
According to the Mayo Clinic, “While all children are capable of contracting the virus that causes COVID-19, they do not get sick as often as adults. Most children have mild symptoms or no symptoms.”